ArticleDiabetes, obesity & metabolism2026
Postprandial Glycemic Control With Automated Insulin Delivery With Control-IQ Technology: The Impact of Meal Composition.
Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Postprandial Glycemic Control With Automated Insulin Delivery With Control-IQ Technology: The Impact of Meal Composition.Diabetes, obesity & metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsTo evaluate the efficiency of the AID system with Control-IQ technology and carbohydrate counting (CHC)-based premeal bolus to control postprandial glucose (PPG) after mixed meals with different macronutrient compositions in adolescents with type 1 diabetes (T1D). MATERIAL AND
methodsIn this prospective crossover study, 25 adolescents with T1D using an automated insulin delivery (AID-Tandem Tslim X2 with Control-IQ) consumed three iso-caloric meals (745 kcal) on separate days: a standard meal (56.5% carbohydrate), a high-fat (HF) meal (45.9% fat), and a high-protein (HP) meal (24.4% protein). A CHC-based bolus was administered 15 min before each meal. Continuous glucose monitoring metrics and AID insulin delivery were assessed over 6 h. The primary outcome was 6-h time in range (TIR, 70-180 mg/dL).
resultsSix-hour TIR was significantly lower after HF (65.2%) and HP meals (49.9%) compared with the standard meal (84.3%) (p < 0.01 and p < 0.001, respectively). Postprandial glucose exposure (AUC above 140 and 180 mg/dL) was significantly higher after HF and HP meals at both 3 and 6 h. The AID system delivered significantly more insulin than the pre-programmed basal for HF (+26% at 6 h, p < 0.05) and HP meals (+55% at 6 h, p < 0.001), without increasing hypoglycemia.
conclusionsDespite a substantial autonomous increase in insulin delivery, AID systems using Control-IQ technology and a standard CHC-based pre-meal bolus have not achieved adequate postprandial glycemic control after HF and HP meals. Proactively timed, meal-specific insulin strategies are required to improve postprandial outcomes after nutritionally complex meals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.